NO940376L - Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet - Google Patents

Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet

Info

Publication number
NO940376L
NO940376L NO940376A NO940376A NO940376L NO 940376 L NO940376 L NO 940376L NO 940376 A NO940376 A NO 940376A NO 940376 A NO940376 A NO 940376A NO 940376 L NO940376 L NO 940376L
Authority
NO
Norway
Prior art keywords
delivery
time
short period
drug over
dosage device
Prior art date
Application number
NO940376A
Other languages
English (en)
Other versions
NO940376D0 (no
Inventor
George V Guittard
Howard A Carpenter
Ernest S Quan
Patrick S L Wong
Lawrence G Hamel
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO940376D0 publication Critical patent/NO940376D0/no
Publication of NO940376L publication Critical patent/NO940376L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen vedrører en doseringsform (10) for oral administrering av et medikament (15) i løpet av 8 timer eller mindre til magen og tynntarmen for å frembringe en terapeutisk virkning. Doseringsformens (10) vegg (12) omfatter et middel (18) for høy fluidfluks og omslutter medikamentet (15) slik at medikamentet (15) kan administreres i løpet av det gitte tidsrom.
NO940376A 1991-08-19 1994-02-07 Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet NO940376L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/747,899 US5178867A (en) 1991-08-19 1991-08-19 Dosage form for delivering drug in short-time period
PCT/US1992/007034 WO1993003711A1 (en) 1991-08-19 1992-08-19 Dosage form for delivering drug in short-time period

Publications (2)

Publication Number Publication Date
NO940376D0 NO940376D0 (no) 1994-02-07
NO940376L true NO940376L (no) 1994-02-07

Family

ID=25007151

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940376A NO940376L (no) 1991-08-19 1994-02-07 Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet

Country Status (17)

Country Link
US (1) US5178867A (no)
EP (1) EP0600033B1 (no)
JP (1) JP2934505B2 (no)
AT (1) ATE129404T1 (no)
AU (1) AU666674B2 (no)
CA (1) CA2112679C (no)
DE (1) DE69205687T2 (no)
DK (1) DK0600033T3 (no)
ES (1) ES2079206T3 (no)
FI (1) FI940787A7 (no)
GR (1) GR3017891T3 (no)
MX (1) MX9204776A (no)
NO (1) NO940376L (no)
NZ (1) NZ244009A (no)
PT (1) PT100789A (no)
WO (1) WO1993003711A1 (no)
ZA (1) ZA926241B (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ATE208615T1 (de) * 1993-07-09 2001-11-15 Scherer Corp R P Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
US5523095A (en) * 1993-12-15 1996-06-04 Eastman Chemical Company Controlled release matrix system using cellulose acetate/polyvinylpyrrolidone blends
US5536505A (en) * 1993-12-15 1996-07-16 Eastman Chemical Company Controlled release matrix system using cellulose acetate/poly-2-ethyl-2-oxazoline blends
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
ATE286394T1 (de) * 1995-09-21 2005-01-15 Pharma Pass Ii Llc Ein säurelabile omeprazol enthaltende arzneizusammensetzung und verfahren zu deren herstellung
KR20010012402A (ko) * 1997-05-09 2001-02-15 세이지 파마슈티칼스, 인크. 안정한 약제학적 경구 투여형
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
ZA9810765B (en) * 1998-05-28 1999-08-06 Ranbaxy Lab Ltd Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US7094426B2 (en) * 1998-08-27 2006-08-22 Sage Pharmaceuticals, Inc. Stable oral pharmaceutical dosage forms
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6326384B1 (en) * 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
FR2797767B1 (fr) * 1999-08-27 2002-06-14 Centre Nat Rech Scient Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
BR0115390A (pt) 2000-11-03 2004-02-25 Andrx Corp Formulações para liberação controlada de metformina, liberação controlada da forma farmacêutica oral, método de diminuição dos nìveis de glicose sanguìnea, uso da forma farmacêutica
AU2003241537A1 (en) * 2002-05-23 2003-12-12 Andrx Corporation Biguanide formulations
US20040005359A1 (en) * 2002-06-27 2004-01-08 Cheng Xiu Xiu Controlled release oral dosage form
AU2003272504A1 (en) 2002-09-20 2004-04-08 Andrx Labs Llc Multistage formulation containing a biguanide and thiazolidindione derivatives
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
WO2004066924A2 (en) * 2003-01-24 2004-08-12 Andrx Labs Llc Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US7051606B2 (en) * 2004-01-30 2006-05-30 Andrx Labs Llc Dosage form holder device and methods for immersion testing
US8461187B2 (en) * 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070123562A1 (en) * 2005-05-25 2007-05-31 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the-night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
DE102005031577A1 (de) 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
ATE438381T1 (de) * 2005-11-18 2009-08-15 Synhton B V Zolpidemtabletten
WO2009049160A1 (en) * 2007-10-12 2009-04-16 Takeda Pharmaceuticals North America Methods of treating gastrointestinal disorders independent of the intake of food
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
IN2014DN09045A (no) 2012-05-07 2015-05-22 Bayer Pharma AG
HUE067496T2 (hu) 2020-12-08 2024-10-28 Ruminant Biotech Corp Ltd Az állatoknak szánt anyagok bejuttatására szolgáló eszközök és módszerek fejlesztése

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4519801A (en) 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4693895A (en) * 1984-10-26 1987-09-15 Alza Corporation Colon delivery system
US4608048A (en) * 1984-12-06 1986-08-26 Alza Corporation Dispensing device with drug delivery patterns
DE3766885D1 (en) * 1986-04-17 1991-02-07 Alza Corp Chlorpheniramine therapie.
US4948592A (en) * 1986-05-09 1990-08-14 Alza Corporation Pulsed drug delivery
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
NZ226822A (en) * 1987-11-16 1990-03-27 Mcneil Consumer Prod Chewable medicament tablet containing means for taste masking
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms

Also Published As

Publication number Publication date
JP2934505B2 (ja) 1999-08-16
AU666674B2 (en) 1996-02-22
AU2544992A (en) 1993-03-16
DE69205687T2 (de) 1996-04-11
DK0600033T3 (da) 1995-12-27
EP0600033B1 (en) 1995-10-25
ZA926241B (en) 1993-10-04
ES2079206T3 (es) 1996-01-01
FI940787A0 (fi) 1994-02-18
NZ244009A (en) 1995-02-24
JPH06509809A (ja) 1994-11-02
MX9204776A (es) 1993-04-01
NO940376D0 (no) 1994-02-07
FI940787L (fi) 1994-02-18
FI940787A7 (fi) 1994-02-18
CA2112679C (en) 2003-04-15
CA2112679A1 (en) 1993-03-04
GR3017891T3 (en) 1996-01-31
EP0600033A1 (en) 1994-06-08
US5178867A (en) 1993-01-12
PT100789A (pt) 1994-05-31
DE69205687D1 (de) 1995-11-30
WO1993003711A1 (en) 1993-03-04
ATE129404T1 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
NO940376L (no) Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet
FI924247A0 (fi) En doseringsform foer frigoerande av medicin till tarmen.
NO306377B1 (no) Doseform for avgivelse av et medikament
ATE222495T1 (de) Oral anzuwendendes flüssiges arzneimittel enthaltend alendronat
ATE280572T1 (de) Verabreichung von arzneistoffen im unteren verdauungstrakt
NO920740D0 (no) Doseringsform for oral administrering av hypoglykemisk glipizid
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
SE9301057L (sv) Beredning med kontrollerad frisättning
IS3959A (is) Aðferð við framleiðslu á blöndu sem samanstendur af lyfi sem er berkjuvíkkandi og bólgueyðandi steralyfi til meðhöndlunar á öndunartruflunum og notkun hennar
IS1858B (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
KR970061244A (ko) 치매 치료용 약학 조성물
AR030039A1 (es) Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
MY100780A (en) Azumolene dosage form.
Courtney et al. Olsalazine in the treatment of ulcerative colitis
RU2002118326A (ru) Применение рофлепонида в лечении синдрома раздражения кишечника (СРК)
DK117291D0 (da) Doseringsform til oral indgift af laegemiddelstoffer
IT1269412B (it) Apparecchio distributore di farmaci